EPA’s Endocrine Disruptor Screening Program Should Establish Management Controls to Ensure More Timely Results
See link below for the full report, report summary, multimedia or any agency follow-up.
See link below for the full report, report summary, multimedia or any agency follow-up.
Without the required testing and an effective system of internal controls, the EPA cannot make measurable progress toward complying with statutory requirements or safeguarding human health and the environment against risks from endocrine-disrupting chemicals.
The coronavirus pandemic impacted Resource Conservation and Recovery Act state program operations and resulted in fewer inspections.
See link below for the full report, report summary, multimedia or any agency follow-up.
The Agency did not consistently comply with travel program requirements, which can lead to mismanagement of the EPA's annual travel expenses, which totaled $52.7 million in fiscal year 2019.
The Fiscal Year 2022 Oversight Plan reflects the priority work that the OIG believes is necessary to keep the EPA, the CSB, and Congress fully informed about issues relating to the administration of Agency programs and operations. It is also important to note that our planning efforts are not static...
See the additional details link below for the full report, report summary, multimedia or any agency follow-up.
See the additional details link below for the full report, report summary, multimedia or any agency follow-up.
This report highlights findings from prior single audit reports to help the EPA prepare to administer an additional $60 billion in funds pursuant to the IIJA. We identified seven areas where noncompliance with applicable federal laws, regulations, and program requirements were most frequent. We...
We reviewed prior oversight reports and identified lessons to help the EPA’s administration and oversight of IIJA grant awards. With IIJA appropriations, the EPA will receive approximately $55 billion in additional funding for grants over a five-year period.